Sector Chart Avalo Therapeutics, Inc.

Equities

AVTX

US05338F3064

Market Closed - Nasdaq 21:00:00 15/05/2024 BST 5-day change 1st Jan Change
10.39 USD -1.98% Intraday chart for Avalo Therapeutics, Inc. -11.42% +14.18%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
10.96M - - - - -
49.18B -
42.11B
40.37B
28.85B
26.09B